30-Second Takeaway
- AR-enhanced training improves objective technical performance in surgical novices.
- Double negative control methods reduce bias from non-compliance in surgical RCTs better than ITT or IV.
Week ending June 6, 2026
Selected evidence briefs for surgical practice: AR training, trial methods, ESPB after cardiac surgery, AI education trial protocol, and MIS risks with ovarian sex-cord tumors
AR training improves novice technical performance but effects vary by experience and task
Systematic review of 11 studies (n=347 trainees across 7 specialties) found objective technical improvements with AR in most trials. Consistent reductions in errors were reported and several studies noted faster learning curves and lower cognitive load. An expertise-reversal effect emerged: novices derived the largest benefits, while experienced surgeons saw diminishing returns. Heterogeneous platforms, outcomes, and limited long-term data mean AR is promising but not universally proven.
Double negative controls mitigate bias from non-compliance in surgical RCT simulations
Simulation study showed DNC estimators maintained low bias, small MSE, and near-nominal coverage across scenarios with 10–40% crossover. Compared with ITT, PP, and AT (severely biased) and IV (high variability), DNC reduced MSE by >90% versus IV at n=100 with 40% crossover. DiD performed well only when equal-confounding assumptions held; its performance fell when assumptions were violated. For trials with expected non-compliance, DNC methods offer superior accuracy but require appropriate negative controls and assumptions.
ESPB yields modest early pain and recovery benefits after median sternotomy, high heterogeneity limits certainty
Meta-analysis of 19 RCTs (N=1344) found modest reductions in 24‑hour pain after median sternotomy (MD −0.65 on 0–10 scale). ESPB was associated with lower opioid consumption and shorter time to extubation (MD −1.28 hours) and ICU stay in sternotomy subgroup. Heterogeneity was substantial (I2 >85%) and prediction intervals often cross null, limiting generalizability across centers. No consistent clinically meaningful benefits were seen in minimally invasive cardiac surgery trials.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.